VIJAYA Vijaya Diagnostic Centre Q4 FY26 results (Jan–Mar 2026) and concall
Vijaya Diagnostic Centre reported a robust Q4 and FY26, with strong revenue growth and significant EBITDA margin expansion driven by volume growth and operating leverage. The company outlined ambitious expansion plans for FY27, including new hubs, spokes, and an automated lab, while maintaining a focus on quality and B2C-centric growth. Management expressed confidence in sustaining double-digit growth in core markets and achieving profitability targets.
You’re reading a preview. Opening the full call uses 1 concall credit.
Sign in to use your monthly call allowance.
What they filed
Q4 FY26: revenue up 26.6%, net profit up 37.1% against the same quarter last year.
| Line item | Q2 FY25 | Q3 FY25 | Q4 FY25 | Q1 FY26 | Q2 FY26 | Q3 FY26 | Q4 FY26 |
|---|---|---|---|---|---|---|---|
| Revenue | 183 | 169 | 173 | 188 | 202 +10% | 205 +21% | 219 +27% |
| EBITDA | 76 | 67 | 69 | 74 | 82 +8% | 86 +28% | 96 +39% |
| Net profit | 42 | 35 | 35 | 39 | 43 +2% | 43 +23% | 48 +37% |
How to read this
₹ crore, as filed. The percentage beside a figure is the change against the same quarter a year earlier — never the quarter before, which would make every seasonal business look like it collapses and booms each year.
Inve summary of a publicly available earnings call transcript; see how call summaries are prepared. Not investment advice.
